{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:52:49Z","timestamp":1781668369852,"version":"3.54.5"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"DOI":"10.1007\/s00586-026-10087-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:59:04Z","timestamp":1781665144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biologic immunomodulators and spinal fusion: evidence, mechanisms, and perioperative considerations"],"prefix":"10.1007","author":[{"given":"Patrick","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Vattipally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katholiki","family":"Troumouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Forshey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Farzad","family":"Maroufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Daniel","family":"Davidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tej D.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lubelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Theodore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"13","key":"10087_CR1","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1001\/jama.2010.338","volume":"303","author":"RA Deyo","year":"2010","unstructured":"Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG (2010) Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 303(13):1259\u20131265. https:\/\/doi.org\/10.1001\/jama.2010.338","journal-title":"JAMA"},{"issue":"10","key":"10087_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki M, Takayanagi H (2019) Osteoimmunology: evolving concepts in bone\u2013immune interactions in health and disease. Nat Rev Immunol 19(10):626\u2013642. https:\/\/doi.org\/10.1038\/s41577-019-0178-8","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10087_CR3","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1053\/j.gastro.2015.08.055","volume":"149","author":"J Torres","year":"2015","unstructured":"Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J (2015) Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease. Gastroenterology 149(7):1716\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2015.08.055","journal-title":"Gastroenterology"},{"issue":"1","key":"10087_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","volume":"7","author":"J Davda","year":"2019","unstructured":"Davda J, Declerck P, Hu-Lieskovan S et al (2019) Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics. J Immunother Cancer 7(1):105. https:\/\/doi.org\/10.1186\/s40425-019-0586-0","journal-title":"J Immunother Cancer"},{"issue":"10055","key":"10087_CR5","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"2","key":"10087_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ten.teb.2008.0038","volume":"14","author":"PM Mountziaris","year":"2008","unstructured":"Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14(2):179\u2013186. https:\/\/doi.org\/10.1089\/ten.teb.2008.0038","journal-title":"Tissue Eng Part B Rev"},{"issue":"5","key":"10087_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/ph3051668","volume":"3","author":"J Cottrell","year":"2010","unstructured":"Cottrell J, O\u2019Connor JP (2010) Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Healing. Pharmaceuticals (Basel) 3(5):1668\u20131693. https:\/\/doi.org\/10.3390\/ph3051668","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10087_CR8","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1002\/jcb.23287","volume":"112","author":"GL Lin","year":"2011","unstructured":"Lin GL, Hankenson KD (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112(12):3491\u20133501. https:\/\/doi.org\/10.1002\/jcb.23287","journal-title":"J Cell Biochem"},{"issue":"4","key":"10087_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.21037\/jss-22-23","volume":"8","author":"GM Malham","year":"2022","unstructured":"Malham GM, Louie PK, Brazenor GA, Mobbs RJ, Walsh WR, Sethi RK (2022) Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes\u2014a narrative review. J Spine Surg 8(4):477\u2013490. https:\/\/doi.org\/10.21037\/jss-22-23","journal-title":"J Spine Surg"},{"key":"10087_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/sci-2022-038","volume":"10","author":"BB Frade","year":"2023","unstructured":"Frade BB, Dias RB, Gemini Piperni S, Bonfim DC (2023) The role of macrophages in fracture healing: a narrative review of the recent updates and therapeutic perspectives. Stem Cell Investig 10:4\u20134. https:\/\/doi.org\/10.21037\/sci-2022-038","journal-title":"Stem Cell Investig"},{"issue":"14","key":"10087_CR11","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.3390\/app13148471","volume":"13","author":"O Georgeanu VAl, Gingu","year":"2023","unstructured":"Georgeanu VAl, Gingu O, Antoniac IV, Manolea HO (2023) Current Options and Future Perspectives on Bone Graft and Biomaterials Substitutes for Bone Repair, from Clinical Needs to Advanced Biomaterials Research. Appl Sci 13(14):8471. https:\/\/doi.org\/10.3390\/app13148471","journal-title":"Appl Sci"},{"issue":"4","key":"10087_CR12","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/jcm12041630","volume":"12","author":"GM Leone","year":"2023","unstructured":"Leone GM, Mangano K, Petralia MC, Nicoletti F, Fagone P, Past (2023) Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. J Clin Med 12(4):1630. https:\/\/doi.org\/10.3390\/jcm12041630","journal-title":"J Clin Med"},{"issue":"15","key":"10087_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/BRS.0000000000000376","volume":"39","author":"BE Stein","year":"2014","unstructured":"Stein BE, Hassanzadeh H, Jain A, Lemma MA, Cohen DB, Kebaish KM (2014) Changing Trends in Cervical Spine Fusions in Patients With Rheumatoid Arthritis. Spine (Phila Pa 1976) 39(15):1178\u20131182. https:\/\/doi.org\/10.1097\/BRS.0000000000000376","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"10087_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","volume":"44","author":"N Nigil Haroon","year":"2014","unstructured":"Nigil Haroon N, Sriganthan J, Al Ghanim N, Inman RD, Cheung AM (2014) Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis. Semin Arthritis Rheum 44(2):155\u2013161. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.008","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10087_CR15","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1177\/21925682241270069","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chi J, Manley B et al (2025) Inflammatory Bowel Disease as a Risk Factor for Complications and Revisions Following Lumbar Discectomy. Global Spine J 15(4):1932\u20131938. https:\/\/doi.org\/10.1177\/21925682241270069","journal-title":"Global Spine J"},{"key":"10087_CR16","doi-asserted-by":"publisher","first-page":"124210","DOI":"10.1016\/j.wneu.2025.124210","volume":"200","author":"X Yan","year":"2025","unstructured":"Yan X, Yang X, Xie H et al (2025) Impact of Inflammatory Bowel Disease on Perioperative Complications in Patients Undergoing Cervical Spine Fusion. World Neurosurg 200:124210. https:\/\/doi.org\/10.1016\/j.wneu.2025.124210","journal-title":"World Neurosurg"},{"key":"10087_CR17","doi-asserted-by":"publisher","first-page":"100604","DOI":"10.1016\/j.xnsj.2025.100604","volume":"22","author":"MM Dhodapkar","year":"2025","unstructured":"Dhodapkar MM, Halperin SJ, Day W et al (2025) Outcomes following single level posterior lumbar fusion in patients with systemic and discoid lupus: A retrospective national database study. North Am Spine Soc J (NASSJ) 22:100604. https:\/\/doi.org\/10.1016\/j.xnsj.2025.100604","journal-title":"North Am Spine Soc J (NASSJ)"},{"issue":"1","key":"10087_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13933","volume":"1442","author":"M Lata","year":"2019","unstructured":"Lata M, Hettinghouse AS, Liu C (2019) Targeting tumor necrosis factor receptors in ankylosing spondylitis. Ann N Y Acad Sci 1442(1):5\u201316. https:\/\/doi.org\/10.1111\/nyas.13933","journal-title":"Ann N Y Acad Sci"},{"key":"10087_CR19","doi-asserted-by":"publisher","unstructured":"Marahleh A, Kitaura H, Ohori F et al (2019) TNF-\u03b1 Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02925","DOI":"10.3389\/fimmu.2019.02925"},{"issue":"1","key":"10087_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jbmr.5650040116","volume":"4","author":"J Pfeilschifter","year":"1989","unstructured":"Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman DG (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 4(1):113\u2013118. https:\/\/doi.org\/10.1002\/jbmr.5650040116","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10087_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E et al (2000) Tumor Necrosis Factor \u03b1 Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf\/Rankl\u2013Rank Interaction. J Exp Med 191(2):275\u2013286. https:\/\/doi.org\/10.1084\/jem.191.2.275","journal-title":"J Exp Med"},{"key":"10087_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bone.2015.12.012","volume":"84","author":"C Sang","year":"2016","unstructured":"Sang C, Zhang Y, Chen F et al (2016) Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by inhibiting semaphorin 3B via Wnt\/\u03b2-catenin signaling in estrogen-deficiency induced osteoporosis. Bone 84:78\u201387. https:\/\/doi.org\/10.1016\/j.bone.2015.12.012","journal-title":"Bone"},{"issue":"12","key":"10087_CR23","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/jbmr.2295","volume":"29","author":"T Mukai","year":"2014","unstructured":"Mukai T, Ishida S, Ishikawa R et al (2014) SH3BP2 Cherubism Mutation Potentiates TNF-\u03b1\u2013Induced Osteoclastogenesis via NFATc1 and TNF-\u03b1\u2013Mediated Inflammatory Bone Loss. J Bone Miner Res 29(12):2618\u20132635. https:\/\/doi.org\/10.1002\/jbmr.2295","journal-title":"J Bone Miner Res"},{"key":"10087_CR24","doi-asserted-by":"publisher","first-page":"102422","DOI":"10.1016\/j.tice.2024.102422","volume":"89","author":"Q Yao","year":"2024","unstructured":"Yao Q, He L, Bao C, Yan X, Ao J (2024) The role of TNF-\u03b1 in osteoporosis, bone repair and inflammatory bone diseases: A review. Tissue Cell 89:102422. https:\/\/doi.org\/10.1016\/j.tice.2024.102422","journal-title":"Tissue Cell"},{"issue":"5","key":"10087_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2\/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation. Cell 89(5):747\u2013754. https:\/\/doi.org\/10.1016\/S0092-8674(00)80257-3","journal-title":"Cell"},{"issue":"3","key":"10087_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/dgd.12207","volume":"57","author":"C Li","year":"2015","unstructured":"Li C, Zhang P, Gu J (2015) miR-29a modulates tumor necrosis factor\u2010 \u03b1 \u2010induced osteogenic inhibition by targeting Wnt antagonists. Dev Growth Differ 57(3):264\u2013273. https:\/\/doi.org\/10.1111\/dgd.12207","journal-title":"Dev Growth Differ"},{"issue":"7","key":"10087_CR27","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1074\/jbc.M509430200","volume":"281","author":"H Kaneki","year":"2006","unstructured":"Kaneki H, Guo R, Chen D et al (2006) Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts. J Biol Chem 281(7):4326\u20134333. https:\/\/doi.org\/10.1074\/jbc.M509430200","journal-title":"J Biol Chem"},{"issue":"6","key":"10087_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.spinee.2021.01.020","volume":"21","author":"MA Gaudiani","year":"2021","unstructured":"Gaudiani MA, Winkelman RD, Ravishankar P, Rabah NM, Mroz TE, Coughlin DJ (2021) The association of preoperative TNF-alpha inhibitor use and reoperation rates in spinal fusion surgery. Spine J 21(6):972\u2013979. https:\/\/doi.org\/10.1016\/j.spinee.2021.01.020","journal-title":"Spine J"},{"key":"10087_CR29","doi-asserted-by":"publisher","unstructured":"Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J (2011) TNF-\u03b1 promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proceedings of the National Academy of Sciences. ;108(4):1585\u20131590. https:\/\/doi.org\/10.1073\/pnas.1018501108","DOI":"10.1073\/pnas.1018501108"},{"key":"10087_CR30","doi-asserted-by":"publisher","first-page":"115569","DOI":"10.1016\/j.bone.2020.115569","volume":"141","author":"JM Wagner","year":"2020","unstructured":"Wagner JM, Schmidt SV, Dadras M et al (2020) TNF-\u03b1 modulation via Etanercept restores bone regeneration of atrophic non-unions. Bone 141:115569. https:\/\/doi.org\/10.1016\/j.bone.2020.115569","journal-title":"Bone"},{"issue":"5","key":"10087_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15252\/emmm.201404487","volume":"7","author":"JK Chan","year":"2015","unstructured":"Chan JK, Glass GE, Ersek A et al (2015) Low-dose < scp>TNF augments fracture healing in normal and osteoporotic bone by up\u2010regulating the innate immune response. EMBO Mol Med 7(5):547\u2013561. https:\/\/doi.org\/10.15252\/emmm.201404487","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10087_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jbspin.2015.10.019","volume":"83","author":"M Clay","year":"2016","unstructured":"Clay M, Mazouyes A, Gilson M, Gaudin P, Baillet A (2016) Risk of postoperative infections and the discontinuation of TNF inhibitors in patients with rheumatoid arthritis: A meta-analysis. Joint Bone Spine 83(6):701\u2013705. https:\/\/doi.org\/10.1016\/j.jbspin.2015.10.019","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10087_CR33","doi-asserted-by":"publisher","first-page":"e001214","DOI":"10.1136\/rmdopen-2020-001214","volume":"6","author":"SM Goodman","year":"2020","unstructured":"Goodman SM, George MD (2020) Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases? RMD Open 6(2):e001214. https:\/\/doi.org\/10.1136\/rmdopen-2020-001214","journal-title":"RMD Open"},{"issue":"9","key":"10087_CR34","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.arth.2022.05.043","volume":"37","author":"SM Goodman","year":"2022","unstructured":"Goodman SM, Springer BD, Chen AF et al (2022) 2022 American College of Rheumatology\/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty 37(9):1676\u20131683. https:\/\/doi.org\/10.1016\/j.arth.2022.05.043","journal-title":"J Arthroplasty"},{"key":"10087_CR35","doi-asserted-by":"publisher","unstructured":"Singh JA, Cameron C, Noorbaloochi S et al (2015) Risk of serious infection in biological treatment of patients with rheumatoid arthritis: A systematic review and meta-analysis. Lancet 386(9990). https:\/\/doi.org\/10.1016\/S0140-6736(14)61704-9","DOI":"10.1016\/S0140-6736(14)61704-9"},{"issue":"10454","key":"10087_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L et al (2024) New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet 404(10454):803\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(24)01029-8","journal-title":"Lancet"},{"issue":"11","key":"10087_CR37","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S1470-2045(25)00429-2","volume":"26","author":"A Di Federico","year":"2025","unstructured":"Di Federico A, Stumpo S, Mantuano F et al (2025) Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis. Lancet Oncol 26(11):1443\u20131453. https:\/\/doi.org\/10.1016\/S1470-2045(25)00429-2","journal-title":"Lancet Oncol"},{"issue":"12","key":"10087_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY, Renal Cell Carcinoma (2024) JAMA 332(12):1001. https:\/\/doi.org\/10.1001\/jama.2024.12848","journal-title":"JAMA"},{"issue":"4","key":"10087_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/CritRevImmunol.2018025874","volume":"38","author":"B Zhao","year":"2018","unstructured":"Zhao B (2018) Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption? Crit Rev Immunol 38(4):253\u2013261. https:\/\/doi.org\/10.1615\/CritRevImmunol.2018025874","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"10087_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00223-013-9794-7","volume":"94","author":"N Kovacic","year":"2014","unstructured":"Kovacic N, Croucher PI, McDonald MM (2014) Signaling between tumor cells and the host bone marrow microenvironment. Calcif Tissue Int 94(1):125\u2013139. https:\/\/doi.org\/10.1007\/s00223-013-9794-7","journal-title":"Calcif Tissue Int"},{"issue":"15","key":"10087_CR41","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMcp2113128","volume":"386","author":"TA Guise","year":"2022","unstructured":"Guise TA, Wysolmerski JJ (2022) Cancer-Associated Hypercalcemia. N Engl J Med 386(15):1443\u20131451. https:\/\/doi.org\/10.1056\/NEJMcp2113128","journal-title":"N Engl J Med"},{"issue":"15","key":"10087_CR42","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","volume":"19","author":"GD Roodman","year":"2001","unstructured":"Roodman GD (2001) Biology of Osteoclast Activation in Cancer. J Clin Oncol 19(15):3562\u20133571. https:\/\/doi.org\/10.1200\/JCO.2001.19.15.3562","journal-title":"J Clin Oncol"},{"key":"10087_CR43","doi-asserted-by":"publisher","unstructured":"Harmer D, Falank C, Reagan MR (2019) Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma. Front Endocrinol (Lausanne) 9. https:\/\/doi.org\/10.3389\/fendo.2018.00788","DOI":"10.3389\/fendo.2018.00788"},{"key":"10087_CR44","doi-asserted-by":"publisher","unstructured":"Wang JW, Dai MW, Liu JH (2025) The regulatory effects of PD-1\/PD-L1 inhibitors on bone metabolism: opportunities and challenges in osteoporosis management. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1630751","DOI":"10.3389\/fimmu.2025.1630751"},{"issue":"8","key":"10087_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/jbmr\/zjaf055","volume":"40","author":"GJ Joseph","year":"2025","unstructured":"Joseph GJ, Vecchi LA III, Uppuganti S et al (2025) Programmed cell death protein 1 (PD-1) blockade regulates skeletal remodeling in a sex- and age-dependent manner. J Bone Miner Res 40(8):950\u2013964. https:\/\/doi.org\/10.1093\/jbmr\/zjaf055","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10087_CR46","doi-asserted-by":"publisher","first-page":"e008669","DOI":"10.1136\/jitc-2023-008669","volume":"12","author":"T Gassner","year":"2024","unstructured":"Gassner T, Chittilappilly C, Pirich T et al (2024) Favorable impact of PD1\/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation. J Immunother Cancer 12(5):e008669. https:\/\/doi.org\/10.1136\/jitc-2023-008669","journal-title":"J Immunother Cancer"},{"issue":"10","key":"10087_CR47","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1096\/fj.201802597RR","volume":"33","author":"D Ke","year":"2019","unstructured":"Ke D, Ji L, Wang Y et al (2019) JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl\u20102\u2010Beclin1\u2010autophagy pathway. FASEB J 33(10):11082\u201311095. https:\/\/doi.org\/10.1096\/fj.201802597RR","journal-title":"FASEB J"},{"key":"10087_CR48","doi-asserted-by":"publisher","unstructured":"Wang JW, Dai MW, Liu JH (2025) The regulatory effects of PD-1\/PD-L1 inhibitors on bone metabolism: opportunities and challenges in osteoporosis management. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1630751","DOI":"10.3389\/fimmu.2025.1630751"},{"key":"10087_CR49","doi-asserted-by":"publisher","unstructured":"Pacifici R (2016) The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH. Front Immunol 7. https:\/\/doi.org\/10.3389\/fimmu.2016.00057","DOI":"10.3389\/fimmu.2016.00057"},{"issue":"4","key":"10087_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/03008207.2020.1759562","volume":"62","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wei Y, Lei L et al (2021) RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2\/STAT3 pathway through autophagy suppression. Connect Tissue Res 62(4):411\u2013426. https:\/\/doi.org\/10.1080\/03008207.2020.1759562","journal-title":"Connect Tissue Res"},{"issue":"9","key":"10087_CR51","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and Type 17 Helper T Cells. N Engl J Med 361(9):888\u2013898. https:\/\/doi.org\/10.1056\/NEJMra0707449","journal-title":"N Engl J Med"},{"issue":"3","key":"10087_CR52","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/ijms26031311","volume":"26","author":"L Wang","year":"2025","unstructured":"Wang L, Ruan M, Bu Q, Zhao C (2025) Signaling Pathways Driving MSC Osteogenesis: Mechanisms, Regulation, and Translational Applications. Int J Mol Sci 26(3):1311. https:\/\/doi.org\/10.3390\/ijms26031311","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10087_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11914-017-0356-1","volume":"15","author":"A Bozec","year":"2017","unstructured":"Bozec A, Zaiss MM (2017) T Regulatory Cells in Bone Remodelling. Curr Osteoporos Rep 15(3):121\u2013125. https:\/\/doi.org\/10.1007\/s11914-017-0356-1","journal-title":"Curr Osteoporos Rep"},{"key":"10087_CR54","doi-asserted-by":"publisher","unstructured":"Wang X, Sun B, Wang Y et al (2024) Research progress of targeted therapy regulating Th17\/Treg balance in bone immune diseases. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1333993","DOI":"10.3389\/fimmu.2024.1333993"},{"key":"10087_CR55","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.actbio.2020.03.017","volume":"108","author":"E J\u00e4msen","year":"2020","unstructured":"J\u00e4msen E, Pajarinen J, Kouri VP et al (2020) Tumor necrosis factor primes and metal particles activate the NLRP3 inflammasome in human primary macrophages. Acta Biomater 108:347\u2013357. https:\/\/doi.org\/10.1016\/j.actbio.2020.03.017","journal-title":"Acta Biomater"},{"issue":"1","key":"10087_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11914-022-00720-3","volume":"20","author":"SB Goodman","year":"2022","unstructured":"Goodman SB, Gibon E, Gallo J, Takagi M (2022) Macrophage Polarization and the Osteoimmunology of Periprosthetic Osteolysis. Curr Osteoporos Rep 20(1):43\u201352. https:\/\/doi.org\/10.1007\/s11914-022-00720-3","journal-title":"Curr Osteoporos Rep"},{"key":"10087_CR57","doi-asserted-by":"publisher","unstructured":"Cong Y, Wang Y, Yuan T et al (2023) Macrophages in aseptic loosening: Characteristics, functions, and mechanisms. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1122057","DOI":"10.3389\/fimmu.2023.1122057"},{"issue":"18","key":"10087_CR58","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMra1514296","volume":"375","author":"VA Boussiotis","year":"2016","unstructured":"Boussiotis VA (2016) Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway. N Engl J Med 375(18):1767\u20131778. https:\/\/doi.org\/10.1056\/NEJMra1514296","journal-title":"N Engl J Med"},{"key":"10087_CR59","doi-asserted-by":"publisher","unstructured":"Greisen SR, Kragstrup TW, Thomsen JS et al (2022) The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.773946","DOI":"10.3389\/fimmu.2022.773946"},{"issue":"15","key":"10087_CR60","doi-asserted-by":"publisher","first-page":"8599","DOI":"10.3390\/ijms23158599","volume":"23","author":"AC Beenen","year":"2022","unstructured":"Beenen AC, Sauerer T, Schaft N, D\u00f6rrie J (2022) Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. Int J Mol Sci 23(15):8599. https:\/\/doi.org\/10.3390\/ijms23158599","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10087_CR61","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hed.26601","volume":"43","author":"AC Mays","year":"2021","unstructured":"Mays AC, Yarlagadda B, Achim V et al (2021) Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer. Head Neck 43(5):1509\u20131520. https:\/\/doi.org\/10.1002\/hed.26601","journal-title":"Head Neck"},{"issue":"7","key":"10087_CR62","doi-asserted-by":"publisher","first-page":"e009309","DOI":"10.1136\/jitc-2024-009309","volume":"12","author":"M Elsayed","year":"2024","unstructured":"Elsayed M, Ye C (2024) Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors? J Immunother Cancer 12(7):e009309. https:\/\/doi.org\/10.1136\/jitc-2024-009309","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10087_CR63","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00198-023-06690-1","volume":"34","author":"C Ye","year":"2023","unstructured":"Ye C, Lee K, Leslie WD, Lin M, Walker J, Kolinsky M (2023) Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event. Osteoporos Int 34(4):735\u2013740. https:\/\/doi.org\/10.1007\/s00198-023-06690-1","journal-title":"Osteoporos Int"},{"issue":"1","key":"10087_CR64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40425-018-0417-8","volume":"6","author":"KF Moseley","year":"2018","unstructured":"Moseley KF, Naidoo J, Bingham CO et al (2018) Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series. J Immunother Cancer 6(1):104. https:\/\/doi.org\/10.1186\/s40425-018-0417-8","journal-title":"J Immunother Cancer"},{"key":"10087_CR65","doi-asserted-by":"publisher","unstructured":"Chan KK, Ghosh N, Aude C, DiCarlo E, Bass AR Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series. J Rheumatol. Published online November 15, 2025:jrheum.2025 \u2013 0696. https:\/\/doi.org\/10.3899\/jrheum.2025-0696","DOI":"10.3899\/jrheum.2025-0696"},{"issue":"1","key":"10087_CR66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12885-019-5741-y","volume":"19","author":"MTJ van Bussel","year":"2019","unstructured":"van Bussel MTJ, Beijnen JH, Brandsma D (2019) Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review. BMC Cancer 19(1):519. https:\/\/doi.org\/10.1186\/s12885-019-5741-y","journal-title":"BMC Cancer"},{"issue":"8","key":"10087_CR67","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.3390\/curroncol30080540","volume":"30","author":"E Sandbank","year":"2023","unstructured":"Sandbank E, Eckerling A, Margalit A, Sorski L, Ben-Eliyahu S (2023) Immunotherapy during the Immediate Perioperative Period: A Promising Approach against Metastatic Disease. Curr Oncol 30(8):7450\u20137477. https:\/\/doi.org\/10.3390\/curroncol30080540","journal-title":"Curr Oncol"},{"issue":"8","key":"10087_CR68","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.3390\/curroncol30080540","volume":"30","author":"E Sandbank","year":"2023","unstructured":"Sandbank E, Eckerling A, Margalit A, Sorski L, Ben-Eliyahu S (2023) Immunotherapy during the Immediate Perioperative Period: A Promising Approach against Metastatic Disease. Curr Oncol 30(8):7450\u20137477. https:\/\/doi.org\/10.3390\/curroncol30080540","journal-title":"Curr Oncol"},{"issue":"10","key":"10087_CR69","doi-asserted-by":"publisher","first-page":"e1913102","DOI":"10.1001\/jamanetworkopen.2019.13102","volume":"2","author":"J Bilal","year":"2019","unstructured":"Bilal J, Berlinberg A, Riaz I, Bin et al (2019) Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors. JAMA Netw Open 2(10):e1913102. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.13102","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10087_CR70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdv.15920","volume":"34","author":"A Egeberg","year":"2020","unstructured":"Egeberg A, Andersen YMF, Halling-Overgaard A, \u2010S. et al (2020) Systematic review on rapidity of onset of action for interleukin\u201017 and interleukin\u201023 inhibitors for psoriasis. J Eur Acad Dermatol Venereol 34(1):39\u201346. https:\/\/doi.org\/10.1111\/jdv.15920","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10087_CR71","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M MERTENS","year":"2009","unstructured":"MERTENS M, SINGH JA (2009) Anakinra for Rheumatoid Arthritis: A Systematic Review. J Rheumatol 36(6):1118\u20131125. https:\/\/doi.org\/10.3899\/jrheum.090074","journal-title":"J Rheumatol"},{"issue":"S3","key":"10087_CR72","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.14444\/8556","volume":"17","author":"SM Bergin","year":"2023","unstructured":"Bergin SM, Crutcher CL, Keeler C et al (2023) Osteoimmunology: Interactions With the Immune System in Spinal Fusion. Int J Spine Surg 17(S3):S9\u2013S17. https:\/\/doi.org\/10.14444\/8556","journal-title":"Int J Spine Surg"},{"issue":"6","key":"10087_CR73","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bone.2007.07.022","volume":"41","author":"X Yang","year":"2007","unstructured":"Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MPG (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41(6):928\u2013936. https:\/\/doi.org\/10.1016\/j.bone.2007.07.022","journal-title":"Bone"},{"issue":"2","key":"10087_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ten.teb.2008.0038","volume":"14","author":"PM Mountziaris","year":"2008","unstructured":"Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14(2):179\u2013186. https:\/\/doi.org\/10.1089\/ten.teb.2008.0038","journal-title":"Tissue Eng Part B Rev"},{"key":"10087_CR75","doi-asserted-by":"publisher","first-page":"618581","DOI":"10.3389\/fimmu.2021.618581","volume":"12","author":"M Mandour","year":"2021","unstructured":"Mandour M, van de Chen S (2021) The Role of the IL-23\/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models. Front Immunol 12:618581. https:\/\/doi.org\/10.3389\/fimmu.2021.618581","journal-title":"Front Immunol"},{"issue":"1","key":"10087_CR76","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.1038\/ncomms10928","volume":"7","author":"T Ono","year":"2016","unstructured":"Ono T, Okamoto K, Nakashima T et al (2016) IL-17-producing \u03b3\u03b4 T cells enhance bone regeneration. Nat Commun 7(1):10928. https:\/\/doi.org\/10.1038\/ncomms10928","journal-title":"Nat Commun"},{"issue":"3","key":"10087_CR77","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10165-012-0683-0","volume":"23","author":"S Momohara","year":"2013","unstructured":"Momohara S, Hashimoto J, Tsuboi H et al (2013) Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study. Mod Rheumatol 23(3):440\u2013449. https:\/\/doi.org\/10.1007\/s10165-012-0683-0","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10087_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ten.teb.2008.0038","volume":"14","author":"PM Mountziaris","year":"2008","unstructured":"Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14(2):179\u2013186. https:\/\/doi.org\/10.1089\/ten.teb.2008.0038","journal-title":"Tissue Eng Part B Rev"},{"issue":"5","key":"10087_CR79","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/ijms23052871","volume":"23","author":"K Maeda","year":"2022","unstructured":"Maeda K, Yoshida K, Nishizawa T et al (2022) Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. Int J Mol Sci 23(5):2871. https:\/\/doi.org\/10.3390\/ijms23052871","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10087_CR80","doi-asserted-by":"publisher","first-page":"17183","DOI":"10.1038\/s41598-023-44374-2","volume":"13","author":"G Adami","year":"2023","unstructured":"Adami G, Orsolini G, Rossini M et al (2023) Changes in bone turnover markers and bone modulators during abatacept treatment. Sci Rep 13(1):17183. https:\/\/doi.org\/10.1038\/s41598-023-44374-2","journal-title":"Sci Rep"},{"issue":"11","key":"10087_CR81","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","volume":"29","author":"OV Britanova","year":"2023","unstructured":"Britanova OV, Lupyr KR, Staroverov DB et al (2023) Targeted depletion of TRBV9 + T cells as immunotherapy in a patient with ankylosing spondylitis. Nat Med 29(11):2731\u20132736. https:\/\/doi.org\/10.1038\/s41591-023-02613-z","journal-title":"Nat Med"},{"issue":"1","key":"10087_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.13643","volume":"1415","author":"S Roser-Page","year":"2018","unstructured":"Roser-Page S, Vikulina T, Weiss D et al (2018) CTLA\u20104Ig (abatacept) balances bone anabolic effects of T cells and Wnt\u201010b with antianabolic effects of osteoblastic sclerostin. Ann N Y Acad Sci 1415(1):21\u201333. https:\/\/doi.org\/10.1111\/nyas.13643","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10087_CR83","doi-asserted-by":"publisher","first-page":"17183","DOI":"10.1038\/s41598-023-44374-2","volume":"13","author":"G Adami","year":"2023","unstructured":"Adami G, Orsolini G, Rossini M et al (2023) Changes in bone turnover markers and bone modulators during abatacept treatment. Sci Rep 13(1):17183. https:\/\/doi.org\/10.1038\/s41598-023-44374-2","journal-title":"Sci Rep"},{"key":"10087_CR84","doi-asserted-by":"publisher","first-page":"kew476","DOI":"10.1093\/rheumatology\/kew476","volume":"3","author":"A Latourte","year":"2017","unstructured":"Latourte A, Gottenberg JE, Luxembourger C et al (2017) Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry. Rheumatol Published online January 3:kew476. https:\/\/doi.org\/10.1093\/rheumatology\/kew476","journal-title":"Rheumatol Published online January"},{"issue":"4","key":"10087_CR85","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3899\/jrheum.181100","volume":"47","author":"H Ito","year":"2020","unstructured":"Ito H, Tsuji S, Nakayama M et al (2020) Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs? J Rheumatol 47(4):502\u2013509. https:\/\/doi.org\/10.3899\/jrheum.181100","journal-title":"J Rheumatol"},{"issue":"1","key":"10087_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41927-020-00173-0","volume":"5","author":"E Choy","year":"2021","unstructured":"Choy E, Groves L, Sugrue D et al (2021) Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study. BMC Rheumatol 5(1):3. https:\/\/doi.org\/10.1186\/s41927-020-00173-0","journal-title":"BMC Rheumatol"},{"issue":"9","key":"10087_CR87","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/art.22046","volume":"54","author":"KGC Smith","year":"2006","unstructured":"Smith KGC, Jones RB, Burns SM, Jayne DRW (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re\u2010treatment. Arthritis Rheum 54(9):2970\u20132982. https:\/\/doi.org\/10.1002\/art.22046","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10087_CR88","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","volume":"40","author":"JCW Edwards","year":"2001","unstructured":"Edwards JCW, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 40(2):205\u2013211. https:\/\/doi.org\/10.1093\/rheumatology\/40.2.205","journal-title":"Rheumatology"},{"key":"10087_CR89","doi-asserted-by":"publisher","unstructured":"Cragg MS, Walshe CA, Ivanov AO, Glennie MJ (2004) The Biology of CD20 and Its Potential as a Target for mAb Therapy. In: B Cell Trophic Factors and B Cell Antagonism in Autoimmune Disease. KARGER, pp 140\u2013174. https:\/\/doi.org\/10.1159\/000082102","DOI":"10.1159\/000082102"},{"issue":"5","key":"10087_CR90","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/rheumatology\/keab643","volume":"61","author":"VY Zhou","year":"2022","unstructured":"Zhou VY, Lacaille D, Lu N et al (2022) Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study. Rheumatology 61(5):1819\u20131830. https:\/\/doi.org\/10.1093\/rheumatology\/keab643","journal-title":"Rheumatology"},{"issue":"8","key":"10087_CR91","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1016\/S2665-9913(20)30033-3","volume":"2","author":"L Garcia-Montoya","year":"2020","unstructured":"Garcia-Montoya L, Villota-Eraso C, Yusof MYM, Vital EM, Emery P (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. Lancet Rheumatol 2(8):e497\u2013e509. https:\/\/doi.org\/10.1016\/S2665-9913(20)30033-3","journal-title":"Lancet Rheumatol"},{"key":"10087_CR92","doi-asserted-by":"publisher","unstructured":"Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S, RANKL\/RANK\/OPG Pathway (2020) A Mechanism Involved in Exercise-Induced Bone Remodeling. Biomed Res Int 2020(1). https:\/\/doi.org\/10.1155\/2020\/6910312","DOI":"10.1155\/2020\/6910312"},{"issue":"9","key":"10087_CR93","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109(9):3839\u20133848. https:\/\/doi.org\/10.1182\/blood-2006-07-037994","journal-title":"Blood"},{"issue":"4","key":"10087_CR94","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/1440-1681.12719","volume":"44","author":"G Sun","year":"2017","unstructured":"Sun G, Wang Y, Ti Y, Wang J, Zhao J, Qian H (2017) Regulatory B cell is critical in bone union process through suppressing proinflammatory cytokines and stimulating Foxp3 in Treg cells. Clin Exp Pharmacol Physiol 44(4):455\u2013462. https:\/\/doi.org\/10.1111\/1440-1681.12719","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"10087_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jocn.2012.05.009","volume":"20","author":"KA Shaikh","year":"2013","unstructured":"Shaikh KA, Helbig GM, Horn EM (2013) Outcomes of spinal fusion following autologous stem cell transplantation. J Clin Neurosci 20(1):62\u201365. https:\/\/doi.org\/10.1016\/j.jocn.2012.05.009","journal-title":"J Clin Neurosci"},{"issue":"11","key":"10087_CR96","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/acr.22056","volume":"65","author":"S Godot","year":"2013","unstructured":"Godot S, Gottenberg J-E, Paternotte S et al (2013) Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) 65(11):1874\u20131879. https:\/\/doi.org\/10.1002\/acr.22056","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"18","key":"10087_CR97","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.3390\/jcm13185531","volume":"13","author":"MS Imam","year":"2024","unstructured":"Imam MS, Alshahrani SA, Alotaibi RMS et al (2024) A Meta-Analysis Examining the Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Medications on Postoperative Wound Complications in Various Orthopedic Surgeries. J Clin Med 13(18):5531. https:\/\/doi.org\/10.3390\/jcm13185531","journal-title":"J Clin Med"},{"issue":"2","key":"10087_CR98","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M22-1034","volume":"176","author":"A Qaseem","year":"2023","unstructured":"Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan T, Cooney TG (2023) Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med 176(2):224\u2013238. https:\/\/doi.org\/10.7326\/M22-1034","journal-title":"Ann Intern Med"},{"issue":"2","key":"10087_CR99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C (2023) Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med 176(2):182\u2013195. https:\/\/doi.org\/10.7326\/M22-0684","journal-title":"Ann Intern Med"},{"key":"10087_CR100","doi-asserted-by":"publisher","first-page":"115048","DOI":"10.1016\/j.bone.2019.115048","volume":"129","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Makras P, Tournis S, Anastasilakis AD (2019) Off-label uses of denosumab in metabolic bone diseases. Bone 129:115048. https:\/\/doi.org\/10.1016\/j.bone.2019.115048","journal-title":"Bone"},{"key":"10087_CR101","doi-asserted-by":"publisher","unstructured":"Walsh MC, Choi Y (2014) Biology of the RANKL- RANK-OPG System in Immunity, Bone, and Beyond. Front Immunol 5. https:\/\/doi.org\/10.3389\/fimmu.2014.00511","DOI":"10.3389\/fimmu.2014.00511"},{"issue":"36","key":"10087_CR102","doi-asserted-by":"publisher","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","volume":"285","author":"DD Pierroz","year":"2010","unstructured":"Pierroz DD, Bonnet N, Baldock PA et al (2010) Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone? J Biol Chem 285(36):28164\u201328173. https:\/\/doi.org\/10.1074\/jbc.M110.101964","journal-title":"J Biol Chem"},{"issue":"2","key":"10087_CR103","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bone.2011.04.001","volume":"49","author":"MS Ominsky","year":"2011","unstructured":"Ominsky MS, Stouch B, Schroeder J et al (2011) Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone 49(2):162\u2013173. https:\/\/doi.org\/10.1016\/j.bone.2011.04.001","journal-title":"Bone"},{"issue":"3suppl","key":"10087_CR104","doi-asserted-by":"publisher","first-page":"61S","DOI":"10.1177\/21925682241289899","volume":"15","author":"Z Sardar","year":"2025","unstructured":"Sardar Z, Coury J, Polly D, Cheung K, Lewis SJ (2025) AO Spine Knowledge Forum Deformity. Osteoporosis in Adult Patients Undergoing Spinal Reconstructive Surgery: Associated Complications and Management. Global Spine J 15(3suppl):61S\u201374S. https:\/\/doi.org\/10.1177\/21925682241289899","journal-title":"Global Spine J"},{"issue":"Supplement1","key":"10087_CR105","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/neuros\/nyab317","volume":"89","author":"J Dimar","year":"2021","unstructured":"Dimar J, Bisson EF, Dhall S et al (2021) Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Osteoporosis Assessment. Neurosurgery 89(Supplement1):S19\u2013S25. https:\/\/doi.org\/10.1093\/neuros\/nyab317","journal-title":"Neurosurgery"},{"issue":"9","key":"10087_CR106","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.spinee.2025.04.018","volume":"25","author":"H Jin","year":"2025","unstructured":"Jin H, Jin H, Suk KS et al (2025) Antiosteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis. Spine J 25(9):1877\u20131898. https:\/\/doi.org\/10.1016\/j.spinee.2025.04.018","journal-title":"Spine J"},{"issue":"4","key":"10087_CR107","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1210\/jc.2010-1502","volume":"96","author":"HG Bone","year":"2011","unstructured":"Bone HG, Bolognese MA, Yuen CK et al (2011) Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass. J Clin Endocrinol Metab 96(4):972\u2013980. https:\/\/doi.org\/10.1210\/jc.2010-1502","journal-title":"J Clin Endocrinol Metab"},{"key":"10087_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis\u20142020 Update. Endocr Pract 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"issue":"7","key":"10087_CR109","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.otsr.2018.07.015","volume":"104","author":"M Ide","year":"2018","unstructured":"Ide M, Yamada K, Kaneko K et al (2018) Combined teriparatide and denosumab therapy accelerates spinal fusion following posterior lumbar interbody fusion. Orthop Traumatology: Surg Res 104(7):1043\u20131048. https:\/\/doi.org\/10.1016\/j.otsr.2018.07.015","journal-title":"Orthop Traumatology: Surg Res"},{"issue":"9","key":"10087_CR110","doi-asserted-by":"publisher","first-page":"e0237566","DOI":"10.1371\/journal.pone.0237566","volume":"15","author":"SH Cheng","year":"2020","unstructured":"Cheng SH, Kuo YJ, Chen C, Kang YN (2020) Effects of teriparatide and bisphosphonate on spinal fusion procedure: A systematic review and network meta-analysis. PLoS ONE 15(9):e0237566. https:\/\/doi.org\/10.1371\/journal.pone.0237566","journal-title":"PLoS ONE"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-10087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-026-10087-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-10087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:59:06Z","timestamp":1781665146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-026-10087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":110,"alternative-id":["10087"],"URL":"https:\/\/doi.org\/10.1007\/s00586-026-10087-z","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}